The latest research study “Renal Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global renal biomarkers market reached a value of US$ 1.13 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 1.88 Billion by 2027, exhibiting a CAGR of 8.70% during 2022-2027.
Renal biomarkers refer to proteins, liquids, microRNAs, metabolites, genes, lipids, or proteomic patterns on a urinalysis. These patterns aid in ascertaining the glomerular filtration rate (GFR) of the kidney to determine its proper functioning and evaluate pathogenic procedures or pharmacological responses to therapeutic interventions. In recent years, renal biomarkers have gained traction in hospital and diagnostic laboratories across the globe due to their ability to predict disease progression and compute drug dosage.
Request for a Free Sample Copy of This Report: https://www.imarcgroup.com/renal-biomarkers-market/requestsample
Renal Biomarkers Market Trends:
One of the primary factors driving the market is the rising prevalence of individuals diagnosed with chronic kidney disease (CKD) and non-communicable diseases with considerable mortality and morbidity. Additionally, renal biomarkers, along with serum creatinine (SCr), blood urea nitrogen (BUN), urinary albumin or protein, and volume excretion, are extensively utilized to diagnose and monitor chronic kidney disease (CKD).
Besides this, there is widespread adoption of novel biomarkers and process-specific biomarker panels as they share prognostic and diagnostic information and assist in predicting the response to the treatment of glomerulopathies, autosomal dominant polycystic kidney disease (ADPKD), and acute kidney injury. Other major growth-inducing factors include the accessibility and feasibility of this product in all-sized laboratories, development and integration of epigenetics, transcriptomics, metabolomics, proteomics and genomics, growing healthcare industry, increasing geriatric population, and rising number of clinical trials for CKD globally.
Click here to view detailed information with table of content: https://bit.ly/3LAomvu
Renal Biomarkers Market 2022-2027 Competitive Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Major Players Covered:
- Abbott Laboratories
- Beckman Coulter Inc. (Danaher Corporation)
- bioMérieux SA
- BioPorto A/S
- Bio-Rad Laboratories Inc.
- Enzo Biochem Inc.
- F. Hoffmann-La Roche AG
- PerkinElmer Inc.
- Randox Laboratories Ltd.
- Siemens AG
- Thermo Fisher Scientific Inc.
Key Market Segmentation:
The report has segmented the market on the basis of region, type, diagnostic technique and end user.
Breakup by Type:
- Functional Biomarker
- Serum Creatinine
- Serum Cystatin C
- Urine Albumin
- Up-regulated Protein
- Neutrophil Gelatinase-Associated Lipocalin (NGAL)
- Kidney Injury Molecule-1
- INTERLEUKIN-18
- Others
Breakup by Diagnostic Technique:
- Enzyme-linked Immunosorbent Assay (ELISA)
- Particle-enhanced Turbidimetric Immunoassay (PETIA)
- Colorimetric Assay
- Chemiluminescent Enzyme Immunoassay (CLIA)
- Liquid Chromatography Mass Spectrometry (LC-MS)
Breakup by End User:
- Hospital
- Diagnostic Laboratory
- Others
Breakup by Region:
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC List of Figure: https://www.imarcgroup.com/request?type=reportid=5273flag=C
Note: We are updating our reports, if you want the report with the latest primary and secondary data (2023-2028) including industry trends, market size and competitive landscape, etc. click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.
Key highlights of the report:
• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Media Contact:
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: sales@imarcgroup.com
Phone: +1-631-791-1145
Address: 134 N 4th St.
City: Brooklyn
State: NY
Country: United States